Facilitating Decentralised Clinical Trials in the EU

  • Home
  • Newsroom
  • Facilitating Decentralised Clinical Trials in the EU
Facilitating Decentralised Clinical Trials in the EU - Axcellant

Facilitating Decentralised Clinical Trials in the EU

  1. gru 19, 2022

The European Commission (EC), the Heads of Medicines Agencies (HMA) and the European Medicines Agency (EMA) have published recommendations that aim to facilitate the conduct of decentralised clinical trials (DCTs) while safeguarding the rights and well-being of participants as well as the robustness and reliability of the data collected.

Patrycja Buczak-Kula

Clinical Trials in the European Union (ACT EU).

https://www.ema.europa.eu/en/news/facilitating-decentralised-clinical-trials-eu

Read more

We are delighted to share exciting news from our team at Axcellant!

Marking a significant achievement in our ongoing efforts to advance medical device research, we have successfully concluded a PMCF study…

Key Considerations for Initiating a Clinical Trial: A Comprehensive Guide

Initiating a clinical trial is akin to embarking on a voyage of discovery in the realm of medicine. This journey,…

Completion of a significant clinical study

Our team at Axcellant is proud to announce the completion of a significant Post-Market Clinical Follow-up study. This study was…